Status:
WITHDRAWN
Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.
Lead Sponsor:
University of Miami
Conditions:
Post-operative Pain
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Able to consent
- BMI\<35
- Exclusion Criteria:
- Adults unable to consent
- BMI\>35
- Individuals \<18 years of age at time of admission
- Individuals taking anticoagulant medications
- Significant co-morbid disease of pregnancy (including: gestational diabetes and significant abnormal placentation)
- Pre-existing chronic pain or pain disorder diagnosis
- Conversion from neuraxial to general anesthesia
- Prisoners
Exclusion
Key Trial Info
Start Date :
July 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06114121
Start Date
July 10 2024
End Date
September 10 2024
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.